Steven Daniel

Steven Daniel is an accomplished professional with extensive experience in the biotechnology and healthcare sectors, particularly in corporate advisory and business development roles. Currently serving as a Corporate Advisor at EMPIRI INC., Steven has previously held notable positions at companies such as REALM IDx, Inc., Akoya Biosciences, and Sprightly Health, contributing to advancements in integrated diagnostics, gene expression analysis, and health technology platforms. With a strong academic background, including a Ph.D. in Molecular Biology from the University of Wisconsin-Madison and postdoctoral training at Stanford University, Steven has a proven track record in driving innovative solutions in cancer research and diagnostics across multiple organizations.